» Articles » PMID: 28561021

CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

Overview
Journal Nat Commun
Specialty Biology
Date 2017 Jun 1
PMID 28561021
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

Although CRISPR/Cas9 genome editing has provided numerous opportunities to interrogate the functional significance of any given genomic site, there is a paucity of data on the extent of molecular scars inflicted on the mouse genome. Here we interrogate the molecular consequences of CRISPR/Cas9-mediated deletions at 17 sites in four loci of the mouse genome. We sequence targeted sites in 632 founder mice and analyse 54 established lines. While the median deletion size using single sgRNAs is 9 bp, we also obtain large deletions of up to 600 bp. Furthermore, we show unreported asymmetric deletions and large insertions of middle repetitive sequences. Simultaneous targeting of distant loci results in the removal of the intervening sequences. Reliable deletion of juxtaposed sites is only achieved through two-step targeting. Our findings also demonstrate that an extended analysis of F1 genotypes is required to obtain conclusive information on the exact molecular consequences of targeting events.

Citing Articles

The mosaicism of Cas-induced mutations and pleiotropic effects of scarlet gene in an emerging model system.

Xu S, Neupane S, Wang H, Pham T, Snyman M, Huynh T Heredity (Edinb). 2025; .

PMID: 39979422 DOI: 10.1038/s41437-025-00750-4.


Base editing of in neurons alleviates symptoms in a mouse model of Parkinson's disease.

Bock D, Wilhelm M, Mumenthaler J, Carpanese D, Kulcsar P, dAquin S Elife. 2024; 13.

PMID: 39714464 PMC: 11666242. DOI: 10.7554/eLife.97180.


Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9.

Amiri M, Moaveni A, Zolbin M, Shademan B, Nourazarian A Front Immunol. 2024; 15:1462697.

PMID: 39582866 PMC: 11581867. DOI: 10.3389/fimmu.2024.1462697.


Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles.

Degtev D, Bravo J, Emmanouilidi A, Zdravkovic A, Choong O, Touza J Nat Commun. 2024; 15(1):9173.

PMID: 39511150 PMC: 11544209. DOI: 10.1038/s41467-024-53418-8.


The design and engineering of synthetic genomes.

James J, Dai J, Chew W, Cai Y Nat Rev Genet. 2024; .

PMID: 39506144 DOI: 10.1038/s41576-024-00786-y.


References
1.
Shen B, Zhang J, Wu H, Wang J, Ma K, Li Z . Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res. 2013; 23(5):720-3. PMC: 3641603. DOI: 10.1038/cr.2013.46. View

2.
Wang L, Shao Y, Guan Y, Li L, Wu L, Chen F . Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci Rep. 2015; 5:17517. PMC: 4664917. DOI: 10.1038/srep17517. View

3.
Chang C, Pasolli H, Giannopoulou E, Guasch G, Gronostajski R, Elemento O . NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche. Nature. 2013; 495(7439):98-102. PMC: 3635831. DOI: 10.1038/nature11847. View

4.
Bae S, Kweon J, Kim H, Kim J . Microhomology-based choice of Cas9 nuclease target sites. Nat Methods. 2014; 11(7):705-6. DOI: 10.1038/nmeth.3015. View

5.
Qin W, Dion S, Kutny P, Zhang Y, Cheng A, Jillette N . Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease. Genetics. 2015; 200(2):423-30. PMC: 4492369. DOI: 10.1534/genetics.115.176594. View